Trientine Hydrochloride
- Product NDC
- 69238-1545
- 11-digit product format
- 692381545
- Labeler code
- 69238
- Product ID
- 69238-1545_b20d3b60-9923-4f06-9ec6-b2e5ba093d2e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Trientine
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA210619
- Marketing category
- ANDA
- Marketing start
- 2019-02-08
- Marketing end
- 0000-00-00
- Substance
- TRIENTINE HYDROCHLORIDE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Metal Chelating Activity [MoA],Metal Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69238-1545 | TRIENTINE HYDROCHLORIDE (TRIENTINE) CAPSULE, GELATIN COATED [AMNEAL PHARMACEUTICALS NY LLC] | 5 | Legacy NDC | 20201230_2cb8b940-881a-4529-92fb-fe4cad168619.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69238-1545-1 | 69238154501 | 100 CAPSULE, GELATIN COATED in 1 BOTTLE (69238-1545-1) | 2019-02-08 | 0000-00-00 | No | No | Current |